ANGIODYNAMICS, INC.

Analyst Reco. AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
6.24 ^USD	+1.13%		+6.48%	-20.41%

May. 21	AngioDynamics Obtains CE Mark Approval in Europe for AlphaVac F18 System	MT
May. 06	AngioDynamics, Inc. Announces Results from the Acute Pulmonary Embolism Extraction Trial with the Alphavac System (APEX-AV)	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target	Apr. 05	MT
Raymond James Adjusts Price Target on AngioDynamics to $10 From $12, Maintains Outperform Rating	Jan. 09	MT
HC Wainwright Adjusts Price Target on AngioDynamics to $18 From $20, Keeps Buy Rating	Jan. 08	MT
Raymond James Adjusts Price Target on AngioDynamics to $12 From $13, Keeps Outperform Rating	23-10-06	MT
HC Wainwright Adjusts AngioDynamics' Price Target to $20 From $19, Keeps Buy Rating	23-10-05	MT
HC Wainwright Starts AngioDynamics at Buy With $19 Price Target	23-09-25	MT
Canaccord Genuity Adjusts AngioDynamics Price Target to $20 From $18, Maintains Buy Rating	23-07-13	MT
Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Target to $13 From $14	23-04-17	MT
Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong Buy Rating	23-04-03	MT
Raymond James Adjusts AngioDynamics' Price Target to $22 From $25, Keeps Strong Buy Rating	23-01-06	MT
Raymond James Adjusts AngioDynamics' Price Target to $25 from $27, Maintains Strong Buy Rating	22-10-07	MT
Raymond James Adjusts AngioDynamics' Price Target to $27 from $32, Keeps Strong Buy Rating	22-07-13	MT
ANGIODYNAMICS : Canaccord Genuity Upgrades AngioDynamics to Buy From Hold, Lifts Price Target to $37 From $28	21-10-15	MT
ANGIODYNAMICS : Oppenheimer Initiates Coverage on AngioDynamics With Perform Rating	21-08-20	MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $28 From $24, Maintains Hold Rating	21-07-14	MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $32 From $27, Keeps Strong Buy Rating	21-07-09	MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $27 from $24, Keeps Strong Buy Rating	21-03-31	MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $24 From $18, Maintains Hold Rating	21-03-31	MT
ANGIODYNAMICS : Raymond James Upgrades AngioDynamics to Strong Buy From Market Perform; Price Target is $18	20-11-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer